Melanotan II

Overview

Melanotan II is a synthetic research peptide that acts as a non-selective melanocortin receptor agonist. It is widely studied in laboratory environments for its potential to stimulate melanogenesis (skin pigmentation) and influence sexual behavior pathways in preclinical models such as laboratory rodents. Melanotan II mimics the natural hormone alpha-melanocyte-stimulating hormone (α-MSH).

Benefits

Preclinical research suggests Melanotan II may promote increased melanin production, leading to darker skin pigmentation in test subjects. It has also been investigated for its ability to stimulate sexual arousal-like responses by activating specific melanocortin receptors. These dual properties make it a valuable compound for research focused on pigmentation and sexual function.
Source: Wessells H, et al. Melanotan II and its effects on penile erection and sexual desire in men with erectile dysfunction. Archives of Sexual Behavior, 2000.

Possible Side Effects

In laboratory settings, test subjects administered Melanotan II have shown mild side effects including facial flushing, temporary nausea-like responses, darkening of moles, or mild injection site irritation. Additional effects may include transient appetite changes or mild fatigue depending on dosage and study conditions.
Source: Wessells H, et al., Archives of Sexual Behavior, 2000.

Dosage & Administration

Melanotan II is typically administered via subcutaneous injection according to approved laboratory research protocols. Common research dosages range from 0.5 mg to 2 mg per injection, with frequency varying from daily to a few times per week depending on study design, species used, and research goals.
For laboratory research use only. Not for human consumption.

Summary

Melanotan II is a synthetic melanocortin receptor agonist peptide developed exclusively for laboratory research exploring skin pigmentation and sexual arousal pathways in preclinical models. Studies indicate it may help increase melanin production and stimulate sexual behavior-like responses, with mild side effects such as flushing or mole darkening occasionally noted in test subjects. Melanotan II is generally administered via subcutaneous injection, with dosage and frequency adjusted according to research objectives and species.
Strictly for research purposes only. Not for human use.